| 產(chǎn)品名稱 |
Equid herpesvirus 1 |
| 商品貨號 |
B161702 |
| Classification |
Herpesviridae, Varicellovirus |
| Deposited As |
Equine Herpes Virus 1(Recombinant) |
| Agent |
Equid herpesvirus 1 |
| Strain |
EHV-1 (dl TK) or EHV-1 (subtype 1) RQ dl TK |
| Common Name |
Equine abortion virus |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
The virus was derived from EHV-1 adapted to vero cells and an EHV-1 recombinant, EHV-1( -gal) TK(-) which expresses the E.Coli beta galactosidase gene |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Effect on Host |
Cytopathic effects (typical herpesvirus CPE, syncytium formation) |
| Recommended Host |
Vero cells (ATCC CCL-81) Vero cells (ATCC CCL-81), E. Derm cells (ATCC CCL-57); horse |
| Growth Conditions |
Temperature: 34.5°C Incubation: 2-3 days |
| Name of Depositor |
S Kit |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
The virus was derived from EHV-1 adapted to vero cells and an EHV-1 recombinant, EHV-1( -gal) TK(-) which expresses the E.Coli beta galactosidase gene |
| References |
Kit M, Kit S. Equine herpesvirus 1 tk mutants. US Patent 5,292,653 dated Mar 8 1994
|
